Last reviewed · How we verify
AK3280 Cream
At a glance
| Generic name | AK3280 Cream |
|---|---|
| Also known as | AK3287 |
| Sponsor | Shanghai Ark Biopharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate the Safety, Tolerability and Efficacy of AK3280 Cream on Hypertrophic Scar (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AK3280 Cream CI brief — competitive landscape report
- AK3280 Cream updates RSS · CI watch RSS
- Shanghai Ark Biopharmaceutical Co., Ltd. portfolio CI